# Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)

Study · id `cardio:ct-nct05465031` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05465031](<https://clinicaltrials.gov/study/NCT05465031>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05465031

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.

## Technical summary

Registry record NCT05465031. Randomized; triple masking; primary purpose prevention. Start 2024-04-17 (actual); primary completion 2027-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 600 participants (planned count; ClinicalTrials.gov record NCT05465031, source copy `cardio:ctgov-nct05465031-2025-03-14`, retrieved 2026-10-26)
- Started: 2024-04-17 (actual) (ClinicalTrials.gov record NCT05465031, source copy `cardio:ctgov-nct05465031-2025-03-14`, retrieved 2026-10-26)
- Primary completion: 2027-12 (anticipated) (ClinicalTrials.gov record NCT05465031, source copy `cardio:ctgov-nct05465031-2025-03-14`, retrieved 2026-10-26)
- Completion: 2029-02 (anticipated) (ClinicalTrials.gov record NCT05465031, source copy `cardio:ctgov-nct05465031-2025-03-14`, retrieved 2026-10-26)
- Countries: Poland (ClinicalTrials.gov record NCT05465031, source copy `cardio:ctgov-nct05465031-2025-03-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05465031-2025-03-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Sacubitril/Valsartan in PriMAry preventIoN of the Cardiotoxicity of Systematic breaST canceR trEAtMent (MAINSTREAM)
- Condition: Breast Cancer
- Condition: Neoplasm, Breast
- Condition: Breast Diseases
- Condition: Antihypertensive Agents
- Condition: Sacubitril/Valsartan
- Condition: Angiotensin II Type 1 Receptor Blockers
- Condition: Angiotensin Receptor Antagonists
- Condition: Molecular Mechanisms of Pharmacological Action
- Condition: Heart Failure
- Condition: Cardiac Toxicity
- Condition: Cancer, Therapy-Related
- Condition: Cancer Therapy-Related Cardiac Dysfunction
- Condition: Cardiotoxicity
- Intervention (Drug): Sacubitril-valsartan
- Intervention (Drug): Placebo
- Lead sponsor: Silesian Centre for Heart Diseases
- Lead sponsor class: OTHER
- Collaborator: Medical Research Agency, Poland
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Sacubitril/valsartan (combination) (`cardio:sacubitril-valsartan`)
- Registry lists this organization as the lead sponsor: Silesian Centre for Heart Diseases (`cardio:org-silesian-centre-for-heart-diseases`)
- Registry lists this organization as a collaborator: Medical Research Agency, Poland (`cardio:org-medical-research-agency-poland`)

## Provenance

Content hash: e30d0411ecdc5b7932aa419a62c28d8c84e1b98487feaa9948ffa350a257d84e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
